Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume → DON’T buy gold until you read this (From Sasco Gold LLC) (Ad) Free AVXL Stock Alerts $3.79 -0.08 (-2.07%) (As of 06/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Anavex Life Sciences Short Interest DataCurrent Short Interest21,860,000 sharesPrevious Short Interest21,290,000 sharesChange Vs. Previous Month+2.68%Dollar Volume Sold Short$98.15 millionShort Interest Ratio17.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares84,640,000 sharesPercentage of Shares Shorted25.83%Today's Trading Volume1,869,771 sharesAverage Trading Volume1,327,541 sharesToday's Volume Vs. Average141% Short Selling Anavex Life Sciences ? Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVXL Short Interest Over TimeAVXL Days to Cover Over TimeAVXL Percentage of Float Shorted Over Time Ad Sasco Gold LLCDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way.Reserve your seat here. Anavex Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202421,860,000 shares $98.15 million +2.7%N/A17.5 $4.49 4/30/202421,290,000 shares $77.71 million -3.3%N/A16.6 $3.65 4/15/202422,010,000 shares $93.10 million -0.5%N/A17.1 $4.23 3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09 3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11 2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14 Get the Latest News and Ratings for AVXL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anavex Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83 1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97 1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99 12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31 12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84 11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21 11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18 10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58 10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05 9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55 9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57 8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90 8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94 7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25 7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42 6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13 6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83 5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24 5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49 4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14 4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88 3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57 3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36 2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52 2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47 1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87 1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58 12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26 12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35 11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82 11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05 10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17 10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60 9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32Don’t make this retirement mistake (Ad)If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.Reserve your seat here. 9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51 8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59 8/15/20228,430,000 shares $100.06 million -3.4%N/A9.6 $11.87 7/31/20228,730,000 shares $89.57 million +5.7%N/A9.3 $10.26 7/15/20228,260,000 shares $104.90 million -5.2%N/A8.8 $12.70 6/30/20228,710,000 shares $87.19 million -8.3%N/A9.7 $10.01 6/15/20229,500,000 shares $76.95 million +6.6%N/A10.6 $8.10 5/31/20228,910,000 shares $81.17 million +1.5%N/A10.1 $9.11 5/15/20228,780,000 shares $75.42 million +8.0%N/A9.4 $8.59 4/30/20228,130,000 shares $69.84 million +3.2%N/A8.5 $8.59 4/15/20227,880,000 shares $87.47 million +3.6%N/A6.9 $11.10 3/31/20227,610,000 shares $93.68 million -5.4%N/A6.3 $12.31 3/15/20228,040,000 shares $85.63 million +2.4%N/A6.6 $10.65 2/28/20227,850,000 shares $86.04 million No ChangeN/A6.6 $10.96 2/15/20227,850,000 shares $99.85 million +34.0%N/A6.4 $12.72 1/31/20225,860,000 shares $76.65 million +21.1%N/A5.1 $13.08 1/15/20224,840,000 shares $69.65 million +7.6%N/A5.2 $14.39 12/31/20214,500,000 shares $78.03 million -6.8%N/A5.3 $17.34 12/15/20214,830,000 shares $92.45 million +0.4%N/A5.8 $19.14 11/30/20214,810,000 shares $93.31 million +9.1%N/A5.9 $19.40 11/15/20214,410,000 shares $94.82 million -14.0%9.9%5.5 $21.50 10/29/20215,130,000 shares $96.14 million +0.4%11.5%6.1 $18.74 10/15/20215,110,000 shares $89.53 million -12.2%11.5%5.3 $17.52 9/30/20215,820,000 shares $104.47 million +3.4%13.1%4.8 $17.95 9/15/20215,630,000 shares $96.10 million -5.5%N/A3.2 $17.07 8/31/20215,960,000 shares $116.16 million -14.1%N/A2.3 $19.49 8/13/20216,940,000 shares $135.68 million +3.7%N/A2.6 $19.55 7/30/20216,690,000 shares $120.09 million -12.0%N/A2.5 $17.95 7/15/20217,600,000 shares $168.42 million -13.3%N/A3.1 $22.16 6/30/20218,770,000 shares $200.48 million +24.9%12.5%3.7 $22.86 6/15/20217,020,000 shares $121.73 million +7.3%10.4%3.8 $17.34 5/28/20216,540,000 shares $81.42 million -0.3%9.7%5.7 $12.45 5/14/20216,560,000 shares $66.65 million -4.9%N/A5 $10.16 4/30/20216,900,000 shares $84.53 million +8.0%N/A4.2 $12.25 4/15/20216,390,000 shares $82.24 million +13.9%N/A1.6 $12.87 3/31/20215,610,000 shares $78.71 million +55.8%N/A1.4 $14.03 3/15/20213,600,000 shares $50.51 million -9.1%N/A0.9 $14.03 2/26/20213,960,000 shares $51.72 million -1.3%N/A1 $13.06 2/12/20214,010,000 shares $50.95 million -23.8%N/A1.1 $12.71 1/29/20215,260,000 shares $33.35 million -5.7%N/A1.4 $6.34 1/15/20215,580,000 shares $33.03 million -0.7%N/A4.3 $5.92 12/31/20205,620,000 shares $30.85 million -16.4%N/A3.7 $5.49 12/15/20206,720,000 shares $34.88 million -9.6%N/A4.5 $5.19 11/30/20207,430,000 shares $39.90 million -3.9%N/A6 $5.37 11/15/20207,730,000 shares $41.59 million +17.3%N/A6.6 $5.38 10/30/20206,590,000 shares $39.41 million -6.9%N/A5.9 $5.98 10/15/20207,080,000 shares $30.73 million -3.7%N/A7.6 $4.34 9/30/20207,350,000 shares $33.44 million -4.2%N/A11.5 $4.55 9/15/20207,670,000 shares $30.83 million +6.5%N/A12 $4.02 8/31/20207,200,000 shares $30.53 million -3.4%N/A9.8 $4.24Don’t make this retirement mistake (Ad)If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.Reserve your seat here. 8/14/20207,450,000 shares $31.22 million +23.1%N/A9.9 $4.19 7/31/20206,050,000 shares $25.53 million -12.3%N/A7.6 $4.22 7/15/20206,900,000 shares $31.33 million +8.0%N/A9.4 $4.54 6/30/20206,390,000 shares $31.44 million +5.1%N/A8.8 $4.92 6/15/20206,080,000 shares $24.81 million -6.0%N/A8.1 $4.08 5/29/20206,470,000 shares $26.59 million -11.5%N/A8.3 $4.11 5/15/20207,310,000 shares $25.59 million -0.1%N/A8.1 $3.50 4/30/20207,320,000 shares $25.33 million -2.4%N/A6.5 $3.46 4/15/20207,500,000 shares $23.78 million +4.0%N/A6.1 $3.17 3/31/20207,210,000 shares $24.30 million -6.0%N/A5.7 $3.37 3/13/20207,670,200 shares $23.62 million +4.4%N/A6.9 $3.08 2/28/20207,350,000 shares $20.65 million +5.9%N/A6.5 $2.81 2/14/20206,940,000 shares $24.64 million +3.4%N/A6.4 $3.55 1/31/20206,710,000 shares $27.44 million +2.9%N/A8.3 $4.09 1/15/20206,520,000 shares $27.71 million +2.4%N/A10.4 $4.25 12/31/20196,370,000 shares $18.60 million -4.8%N/A11.3 $2.92 11/29/20196,200,000 shares $14.63 million +1.1%12.3%13.4 $2.36 AVXL Short Interest - Frequently Asked Questions What is Anavex Life Sciences' current short interest? Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 21,860,000 shares of AVXL short. Learn More on Anavex Life Sciences' current short interest. What is a good short interest ratio for Anavex Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 18.0. Learn More on Anavex Life Sciences's short interest ratio. Which institutional investors are shorting Anavex Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anavex Life Sciences: PEAK6 Investments LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Anavex Life Sciences' short interest increasing or decreasing? Anavex Life Sciences saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 21,860,000 shares, an increase of 2.7% from the previous total of 21,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anavex Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Anavex Life Sciences: BioCryst Pharmaceuticals, Inc. (16.64%), Cullinan Therapeutics, Inc. (11.90%), 4D Molecular Therapeutics, Inc. (18.67%), Tarsus Pharmaceuticals, Inc. (19.77%), Ginkgo Bioworks Holdings, Inc. (19.74%), Autolus Therapeutics plc (1.22%), Immatics (10.28%), Relay Therapeutics, Inc. (8.96%), Inhibrx, Inc. (3.91%), Mesoblast Limited (0.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Anavex Life Sciences stock? Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anavex Life Sciences? A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further. How often is Anavex Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BCRX Short Interest Data CGEM Short Interest Data FDMT Short Interest Data TARS Short Interest Data DNA Short Interest Data AUTL Short Interest Data IMTX Short Interest Data RLAY Short Interest Data INBX Short Interest Data MESO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVXL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.